AQR Capital Management
SMTI icon

AQR Capital Management’s Sanara MedTech SMTI Stock Holding History

AQR Capital Management’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$686K Buy
+39,938
New +$822K ﹤0.01% 2971

Other funds holding SMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

AQR Capital Management's SMTI Position: Q1 2026 in Review

AQR Capital Management opened a new position in Sanara MedTech (SMTI) in Q1 2026: 39,938 shares worth $686K. The stake represents ﹤0.01% of the portfolio and ranks #2971 among its holdings.

65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

  • AQR Capital Management held 39,938 shares of Sanara MedTech worth $686K as of Q1 2026.
  • Sanara MedTech was a new AQR Capital Management position in Q1 2026.
  • Sanara MedTech made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2971 holding.
  • 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.